Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00122421 · ClinicalTrials.gov registry record · NA

The Impact of Pharmacist Recommendations on Quality of Care in Diabetic Patients

A NA study, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
300
Enrollment target

NCT00122421 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 300 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00122421, a NA study, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
300 participants
Enrollment target

Study Summary

The goal of this study is to investigate a comprehensive provider-focused intervention to improve the quality of care for diabetic patients in a large primary care practice at Brigham and Women's Hospital. This will be accomplished through pharmacist recommendations provided to primary care providers prior to routine scheduled office visits for diabetic patients.

Interventions

  • BEHAVIORAL Pharmacist recommendations to primary care providers
  • OTHER pharmacist recommendations

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2003-06
Est. Completion 2010-02
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT00122421

The ClinicalTrials.gov registry entry for NCT00122421 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Pharmacist recommendations to primary care providers is the first listed.

NCT00122421 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00122421 about?

NCT00122421 is a clinical study titled "The Impact of Pharmacist Recommendations on Quality of Care in Diabetic Patients". The goal of this study is to investigate a comprehensive provider-focused intervention to improve the quality of care for diabetic patients in a large primary care practice at Brigham and Women's Hospital. This will be accomplished through pharmacist recommendations provided to primary care provider...

What is the current status of trial NCT00122421?

This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2003-06. Estimated completion is 2010-02.

What interventions are being tested in trial NCT00122421?

The interventions under investigation include: Pharmacist recommendations to primary care providers (BEHAVIORAL), pharmacist recommendations (OTHER).

Who is sponsoring clinical trial NCT00122421?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.